These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32278036)

  • 1. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis.
    Luo X; Liu J; Wang H; Lu H
    Pharmacol Res; 2020 Jun; 156():104805. PubMed ID: 32278036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer.
    Liu C; Qin H; Liu H; Wei T; Wu Z; Shang M; Liu H; Wang A; Liu J; Shang D; Yin P
    Front Oncol; 2022; 12():991051. PubMed ID: 36119530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
    He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
    Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
    Ritchie SA; Akita H; Takemasa I; Eguchi H; Pastural E; Nagano H; Monden M; Doki Y; Mori M; Jin W; Sajobi TT; Jayasinghe D; Chitou B; Yamazaki Y; White T; Goodenowe DB
    BMC Cancer; 2013 Sep; 13():416. PubMed ID: 24024929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
    Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
    Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
    Xiong Y; Shi C; Zhong F; Liu X; Yang P
    Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
    Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
    SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD
    Wang S; Chen J; Li H; Qi X; Liu X; Guo X
    Technol Cancer Res Treat; 2021; 20():15330338211045204. PubMed ID: 34605330
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
    Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
    Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
    LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer screening using a multiplatform human serum metabolomics system.
    Sakai A; Suzuki M; Kobayashi T; Nishiumi S; Yamanaka K; Hirata Y; Nakagawa T; Azuma T; Yoshida M
    Biomark Med; 2016 Jun; 10(6):577-86. PubMed ID: 27171159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
    Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-metabolite panel for early-stage pancreatic cancer.
    Burki TK
    Lancet Oncol; 2018 Oct; 19(10):e512. PubMed ID: 30146244
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer.
    Liu F; Du F; Chen X
    World J Surg Oncol; 2014 Nov; 12():333. PubMed ID: 25381564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer.
    Yuan W; Tang W; Xie Y; Wang S; Chen Y; Qi J; Qiao Y; Ma J
    Oncotarget; 2016 Nov; 7(48):80033-80045. PubMed ID: 27713117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.
    Luo G; Liu C; Guo M; Cheng H; Lu Y; Jin K; Liu L; Long J; Xu J; Lu R; Ni Q; Yu X
    Ann Surg; 2017 Apr; 265(4):800-805. PubMed ID: 28267695
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.